APA (7th ed.) Citation

Wang, H., Guo, H., Yang, J., Liu, Y., Liu, X., Zhang, Q., & Zhou, K. (2022). Bruton tyrosine kinase inhibitors in B-cell lymphoma: Beyond the antitumour effect. Experimental Hematology & Oncology, 11(1), 1. https://doi.org/10.1186/s40164-022-00315-9

Chicago Style (17th ed.) Citation

Wang, Haoran, Hao Guo, Jingyi Yang, Yanyan Liu, Xingchen Liu, Qing Zhang, and Keshu Zhou. "Bruton Tyrosine Kinase Inhibitors in B-cell Lymphoma: Beyond the Antitumour Effect." Experimental Hematology & Oncology 11, no. 1 (2022): 1. https://doi.org/10.1186/s40164-022-00315-9.

MLA (9th ed.) Citation

Wang, Haoran, et al. "Bruton Tyrosine Kinase Inhibitors in B-cell Lymphoma: Beyond the Antitumour Effect." Experimental Hematology & Oncology, vol. 11, no. 1, 2022, p. 1, https://doi.org/10.1186/s40164-022-00315-9.